Foundry Partners’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-47,180
Closed -$1.8M 343
2022
Q4
$1.8M Sell
47,180
-3,676
-7% -$140K 0.1% 199
2022
Q3
$1.99M Buy
50,856
+8,264
+19% +$324K 0.13% 196
2022
Q2
$1.38M Buy
+42,592
New +$1.38M 0.08% 218